FDA inspection
SpecGx LLC: FDA inspection ending Nov 22, 2016
FDA inspection 994662 · Voluntary Action Indicated (VAI) · Saint Louis, MO
Key facts
| Inspection ID | 994662 |
|---|---|
| Firm | SpecGx LLC |
| FEI number | 1940521 |
| Address | 3600 N 2nd St |
| City | Saint Louis |
| State | MO |
| ZIP | 63147 |
| Country | United States |
| Fiscal year | 2017 |
| Inspection end date | Nov 22, 2016 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data